Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients

Figure 4 Changes of CD8+CD38+ T cell subsets and median hepatitis B virus DNA, by study week. A: Median CD8+CD38+ T cell proportions in good responders. ^bP < 0.01; B: Changes of CD8+CD38+ T cell subsets in 4 non-responding patients 008, 014, 015, and 018. Among them, Patient 008 and 015 only finished 60 and 48 wk of treatment, respectively. Patient 014 and 018 completed 72 wk of treatment. HBV: Hepatitis B virus.